rs41457746

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_000517.6(HBA2):​c.96-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 9)
Exomes 𝑓: 0.000041 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HBA2
NM_000517.6 splice_acceptor, intron

Scores

2
2
2
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 8.62

Publications

1 publications found
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Heinz body anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • unstable hemoglobin disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 3.4, offset of 28, new splice context is: tgtccttccccaccaccaAGacc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PP5
Variant 16-173123-A-G is Pathogenic according to our data. Variant chr16-173123-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 15679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000517.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
NM_000517.6
MANE Select
c.96-2A>G
splice_acceptor intron
N/ANP_000508.1D1MGQ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
ENST00000251595.11
TSL:1 MANE Select
c.96-2A>G
splice_acceptor intron
N/AENSP00000251595.6P69905
HBA2
ENST00000484216.1
TSL:1
c.63-2A>G
splice_acceptor intron
N/AENSP00000495899.1A0A2R8Y7C0
HBA2
ENST00000482565.1
TSL:1
n.230A>G
non_coding_transcript_exon
Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000332
AC:
2
AN:
60196
Hom.:
0
Cov.:
9
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000595
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000104
AC:
1
AN:
96206
AF XY:
0.0000200
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000289
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000409
AC:
23
AN:
562962
Hom.:
0
Cov.:
7
AF XY:
0.0000539
AC XY:
16
AN XY:
297030
show subpopulations
African (AFR)
AF:
0.0000700
AC:
1
AN:
14278
American (AMR)
AF:
0.00
AC:
0
AN:
33034
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17258
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31228
South Asian (SAS)
AF:
0.00
AC:
0
AN:
56216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29842
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2284
European-Non Finnish (NFE)
AF:
0.0000573
AC:
20
AN:
348964
Other (OTH)
AF:
0.0000670
AC:
2
AN:
29858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000332
AC:
2
AN:
60196
Hom.:
0
Cov.:
9
AF XY:
0.00
AC XY:
0
AN XY:
27086
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
9464
American (AMR)
AF:
0.00
AC:
0
AN:
6126
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1826
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2444
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1284
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4028
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000595
AC:
2
AN:
33632
Other (OTH)
AF:
0.00
AC:
0
AN:
784
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
not provided (3)
1
-
-
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693823:Erythrocytosis, familial, 7 (1)
1
-
-
Alpha-thalassemia, Dutch type (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Benign
-0.14
CADD
Pathogenic
34
DANN
Benign
0.96
Eigen
Pathogenic
0.87
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.90
D
PhyloP100
8.6
GERP RS
4.2
PromoterAI
-0.070
Neutral
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.78
SpliceAI score (max)
1.0
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.68
Position offset: 30
DS_AL_spliceai
1.0
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41457746; hg19: chr16-223122; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.